Overview of Forced Degradation Analysis for FDA Approved Antiretroviral agents: A Review
1, 2, 1, 1★★ Corresponding author
- 1Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, INDIA.
- 2Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, INDIA.
CORRESPONDENCE
Mari Raju Jeyaprakash
Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, INDIA.
Received: 13-04-2022; Revised: 27-05-2022; Accepted: 06-06-2022.
Volume 14, Issue 3 · pp. 273-282 · 2022 · DOI: 10.5530/jyp.2022.14.55
ABSTRACT
Forced degradation and its analysis play a crucial role in the development and production of pharmaceutical products at various stages. Such studies include the assessment of appropriate drug candidates, product development, as well as comparability studies, clarification of probable intermediates and identification of by-products, and the development of stability-indicating technologies. The stability of drugs can be analyzed with Forced degradation study, which gives perspective knowledge of the molecule’s stability as well as the degradant that is produced during the drug’s shelf life. In this review on stability-indicating methods for FDA approved antiretroviral drugs from (1987-2021) such as Zidovudine, Lamivudine, Nevirapine, Ritonavir, Abacavir, Efavirenz, Tenofovir, Atazanavir, Emtricitabine, Enfuvirtide, Fosamprenavir, Tipranavir, Darunavir, Maraviroc, Raltegravir Etravirine, Nevirapine, Rilpivirine, Dolutegravir, Cobistat, Doravirine, Fostemsavir, and Cabotegravir is mentioned and analytical tools like HPLC, LC-MS/MS, UPLC their different parameters for the chromatographic condition are mentioned. No such guideline is available that mentions the pH for hydrolysis, the temperature at which thermal deterioration occurs, and the concentration of oxidation agent for oxidative degradation. The regulatory necessities for the shortcomings of the above-mentioned methods were highlighted. As a result, this study addresses recent approaches for forced degradation by presenting techniques for accessing studies on degradation mechanisms, this review helps researchers to get information on stability-indicating methods for FDA Approved antiretroviral agents for their development and validation of stability indicating methods and the characterization of degradation products produced during degradation studies.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Lamichhane, S., Das, B., Adhikari, R. P., & Jeyaprakash, M. R. (2022). Overview of Forced Degradation Analysis for FDA Approved Antiretroviral agents: A Review. Journal of Young Pharmacists, 14(3), 273-282. https://doi.org/10.5530/jyp.2022.14.55
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
